Not all bone loss created equal.
Eisenberger
Y S
YS
D016301:Alveolar Bone Loss / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001862:Bone Resorption / Q000517:prevention & control*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007571:Jaw Diseases / Q000517:prevention & control*; D020910:Ketorolac; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014087:Tooth Movement Techniques / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D014046:Tolmetin; D020910:Ketorolac